P. Walden

发表

Exact prediction of a natural T cell epitope

Peter Walden, H. Rammensee, S. Stevanović, 1991, European journal of immunology.

Gene therapy of cancer.

F. Farzaneh, W. Sterry, U. Trefzer, 1998, Immunology today.

Exhaustive proteome mining for functional MHC-I ligands.

Gisbert Schneider, Gerd Folkers, Jan A Hiss, 2013, ACS chemical biology.

Design of MHC I stabilizing peptides by agent-based exploration of sequence space.

Gisbert Schneider, Jan A Hiss, Paul Wrede, 2007, Protein engineering, design & selection : PEDS.

Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells

C. Lehr, M. Gottschaldt, J. Czaplewska, 2015, Oncoimmunology.

Analysis of a naturally occurring HLA class I-restricted viral epitope.

V. Gnau, H. Rammensee, S. Stevanović, 1994, Immunology.

Extended presentation of specific MHC‐peptide complexes by mature dendritic cells compared to other types of antigen‐presenting cells

Y. Reiter, D. Zehn, P. Walden, 2004, European journal of immunology.

Combining R-DOTAP and a particulate antigen delivery platform to trigger dendritic cell activation: Formulation development and in-vitro interaction studies.

K. Mäder, P. Walden, R. Baleeiro, 2017, International journal of pharmaceutics.

Determination of T cell epitopes with random peptide libraries.

S. Kienle, T. Junt, K. Wiesmüller, 1996, Journal of immunological methods.

Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL.

S. Kienle, T. Junt, K. Wiesmüller, 1996, Journal of immunology.

Vaccination with hybrids of tumor and dendritic cells induces tumor‐specific T‐cell and clinical responses in melanoma stage III and IV patients

K. Sparbier, W. Sterry, A. Milling, 2004, International journal of cancer.

The future of vaccination as a treatment strategy in dermatological diseases

W. Sterry, P. Walden, 2002, Clinical and experimental dermatology.

Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.

P. Walden, S. Gross, 2008, Immunology letters.

Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure.

W. Sterry, U. Trefzer, P. Walden, 2008, Gene.

Amino acid preferences in the octapeptide subunit of the major histocompatibility complex class I heterotrimer H-2Ld.

S. Kienle, K. Wiesmüller, P. Walden, 1996, European journal of biochemistry.

Testing the Role of gp96 as Peptide Chaperone in Antigen Processing*

P. Walden, Rodion Demine, 2005, Journal of Biological Chemistry.

Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo

Avital Lev, Y. Reiter, D. Zehn, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Cutaneous malignant lymphomas.

K. Asadullah, W. Sterry, S. Jahn, 1998, Immunology today.

N‐glycosylation and biological activity of recombinant human alpha1‐antitrypsin expressed in a novel human neuronal cell line

V. Sandig, U. Marx, V. Blanchard, 2011, Biotechnology and bioengineering.

A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone.

H. Eisen, P. Walden, K. Udaka, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation

J. Neefjes, H. Spits, F. Momburg, 1992, Nature.

Differential arginine methylation of the G‐protein pathway suppressor GPS‐2 recognized by tumor‐specific T cells in melanoma

U. Trefzer, P. Walden, S. Jarmalavicius, 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Polyclonal expansion of T cells with the TCR Vβ type of the tumour cell in lesions of cutaneous T‐cell lymphoma: evidence for possible superantigen involvement

A. Lukowsky, W. Sterry, P. Walden, 2004, The British journal of dermatology.

Genomic aberrations and survival in cutaneous T cell lymphomas.

J. Muche, W. Sterry, H. Tönnies, 2004, The Journal of investigative dermatology.

Altered Allogeneic Response in Neonatally Anti‐MHC Class I‐Treated Mice

K. Sparbier, P. Walden, N. Knezevic, 1996, Scandinavian journal of immunology.

Therapeutic vaccination for cancer immunotherapy: Antigen selection and clinical responses

P. Walden, F. Losch, A. Geldmacher, 2011, Human vaccines.

Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccines.

T. Sharav, P. Walden, F. Losch, 2009, Vaccine.

Exposure to Melan-A/MART-126-35 tumor epitope specific CD8+T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS)

D. Schadendorf, P. Kloetzel, E. Krüger, 2016, Scientific Reports.

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

A. Gross, L. Kanz, P. Brossart, 2000, Nature Medicine.

Mimetics of a T Cell Epitope Based on Poly-N-acylated Amine Backbone Structures Induce T Cells in Vitro andin Vivo *

A. Bianco, G. Jung, P. Walden, 2001, The Journal of Biological Chemistry.

New Synthetic Non-peptide Ligands for Classical Major Histocompatibility Complex Class I Molecules*

T. Walk, A. Bianco, G. Jung, 1998, The Journal of Biological Chemistry.

The hybrid cell vaccination approach to cancer immunotherapy.

W. Sterry, G. Herberth, U. Trefzer, 2000, Ernst Schering Research Foundation workshop.

Direct Activation of Human Dendritic Cells by Particle-Bound but Not Soluble MHC Class II Ligand

K. Wiesmüller, J. Lademann, L. Dähne, 2013, PloS one.

Cutting edge: N-hydroxy peptides: a new class of TCR antagonists.

G. Jung, A. Bianco, P. Walden, 1999, Journal of immunology.

N‐hydroxy‐amide analogues of MHC‐class I peptide ligands with nanomolar binding affinities

G. Jung, A. Bianco, P. Walden, 1998, Journal of peptide science : an official publication of the European Peptide Society.

CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.

P. Walden, K. Udaka, S. Marusić-Galesić, 1994, Journal of immunology.

Immature human DCs efficiently translocate endocytosed antigens into the cytosol for proteasomal processing

P. Walden, R. Baleeiro, 2017, Molecular immunology.

Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.

Y. Reiter, D. Zehn, P. Walden, 2006, International immunology.

Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.

K. Wiesmüller, P. Walden, E. Borges, 1994, Journal of immunological methods.

Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma

W. Sterry, G. Herberth, U. Trefzer, 2000, International journal of cancer.

Symposium article A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma

W. Sterry, P. Walden, S. Gellrich, 2005 .

Antigen presentation by liposomes as model system for T‐B cell interaction

P. Walden, 1988, European journal of immunology.

Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells.

J. Eberle, W. Sterry, C. Assaf, 2007, The Journal of investigative dermatology.

Collaboration of helper and cytotoxic T lymphocytes

P. Walden, G. Stuhler, Peter Walden, 1993, European journal of immunology.

T cell response to myoglobin: a comparison of T cell clones in high‐responder and low‐responder mice

J. Klein, M. Aihara, P. Walden, 1988, European journal of immunology.

Hybrid-cell vaccines for cancer immune therapy

U. Trefzer, P. Walden, 2003, Molecular biotechnology.

Hybrid cell vaccination for cancer immunotherapy.

P. Walden, 2000, Advances in experimental medicine and biology.

Hybrid cell vaccination in patients with metastatic melanoma.

W. Sterry, U. Trefzer, P. Walden, 2000, Methods in molecular medicine.

A phase I trial with a hybrid cell vaccine in patients with metastatic melanoma.

W. Sterry, Y. Guo, U. Trefzer, 1998, Advances in experimental medicine and biology.

Topical vaccination with functionalized particles targeting dendritic cells.

K. Wiesmüller, J. Lademann, A. Patzelt, 2013, The Journal of investigative dermatology.

Efficient Generation of Major Histocompatibility Complex Class I-Peptide Complexes Using Synthetic Peptide Libraries*

P. Barker, K. Wiesmüller, E. Joly, 1998, The Journal of Biological Chemistry.

Gene Therapy of Cancer

F. Farzaneh, W. Sterry, U. Trefzer, 1998, Advances in Experimental Medicine and Biology.

Heterogeneity of Leishmania donovani Parasites Complicates Diagnosis of Visceral Leishmaniasis: Comparison of Different Serological Tests in Three Endemic Regions

S. Sundar, R. Piarroux, Cholho Kang, 2015, PloS one.

Antigen presentation by liposomes: Inhibition with antibodies

J. Klein, Z. Nagy, P. Walden, 1986, European journal of immunology.

Antigen presentation by liposomes.

J. Klein, Z. Nagy, P. Walden, 1985, Haematology and blood transfusion.

Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis

S. Sundar, Michael Forgber, C. Mandal, 2009, Glycoconjugate Journal.

Role of IL‐10 and TGF‐β in melanoma

P. Walden, A. P. Wiguna, 2015, Experimental dermatology.

Composition of a Suppressor Factor That Inhibits the Immune Response to Lactate Dehydrogenase B

J. Klein, Z. Nagy, P. Walden, 1984, Scandinavian journal of immunology.

Influence of the Vehicle on the Penetration of Particles into Hair Follicles

W. Sterry, K. Wiesmüller, J. Lademann, 2011, Pharmaceutics.

Chemical and biological quality of a CTL epitope modified in a stepwise fashion from defined positions to mixture positions

S. Kienle, G. Jung, K. Wiesmüller, 1995 .

Functional determinants of MHC class I-peptide and T cell receptor-MHC-peptide interactions defined with peptide libraries

S. Kienle, K. Wiesmüller, P. Walden, 1995 .

Experimental limits of the peptide library concept

K. Wiesmüller, A. Beck‐Sickinger, G. Jung, 1994 .

Topical nanoparticle vaccine for immune stimulation of dendritic cells in the skin

K. Wiesmüller, J. Lademann, L. Dähne, 2011 .

Distribution of alloreactivity among antigen-specific, class II-restricted T-cell clones and hybridomas

J. Klein, T. Nagatani, Z. Nagy, 2004, Immunogenetics.

Antigen Processing: A Reevaluation

J. Klein, Z. Nagy, P. Walden, 1985 .

Identification of epitopes for CTCL-specific cytotoxic T lymphocytes.

K. Sparbier, A. Lukowsky, W. Sterry, 1998, Advances in experimental medicine and biology.

Mimotope vaccines for cancer immunotherapy.

K. Wiesmüller, T. Sharav, P. Walden, 2007, Vaccine.

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages.

Syamal Roy, P. Walden, R. Basu, 2007, The Journal of infectious diseases.

Nanoparticle-Based Mucosal Vaccines Targeting Tumor-Associated Antigens to Human Dendritic Cells.

C. Lehr, M. Gottschaldt, J. Czaplewska, 2016, Journal of biomedical nanotechnology.

Hybrid Cell Vaccination Resolves Leishmania donovani Infection by Eliciting a Strong CD8+ Cytotoxic T-Lymphocyte Response with Concomitant Suppression of Interleukin-10 (IL-10) but Not IL-4 or IL-13

S. K. Dana, Syamal Roy, T. De, 2007, Infection and Immunity.

Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma

W. Sterry, Michael Forgber, T. Sharav, 2009, PloS one.

Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human Leishmaniasis

S. Croft, F. Modabber, C. Jaffe, 2014, Science Translational Medicine.

Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis

P. Kaye, Deborah F. Smith, T. Aebischer, 2012, The Journal of infectious diseases.

Interrelationship of Tumour and Immune System

P. Walden, 2004 .

Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients

R. Dummer, K. Schwarz, D. Speiser, 2010, Journal of immunotherapy.

Dominance of nonmalignant T-cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disorders.

A. Lukowsky, W. Sterry, M. Beyer, 2009, The Journal of investigative dermatology.

Increased number of cytotoxic T cells within CD4+8− T cells in β2‐microglobulin, major histocompatibility complex class I‐deficient mice

P. Walden, K. Udaka, S. Marusić-Galesić, 1993, European journal of immunology.

Absence of microsatellite instability and lack of evidence for subclone diversification in the pathogenesis and progression of mycosis fungoides.

A. Lukowsky, W. Sterry, C. Assaf, 2007, The Journal of investigative dermatology.

T-cell epitope mapping by flow cytometry

J. Schneider-Mergener, A. Scheffold, Andreas Radbruch, 1998, Nature Medicine.

Can Oral Sucrose Reduce the Pain and Distress Associated with Screening for Retinopathy of Prematurity?

N. Hussain, T. Lerer, V. Herson, 2005, Journal of Perinatology.

H-2 haplotypes carrying identical D but different L alleles.

J. Klein, F. Figueroa, Z. Nagy, 2008, Tissue antigens.

Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin‐mediated killing

Y. Stierhof, S. Pyarajan, S. Burakoff, 2004, European journal of immunology.

MHC I Stabilizing Potential of Computer-Designed Octapeptides

Natalie Jäger, Gisbert Schneider, Paul Wrede, 2010, Journal of biomedicine & biotechnology.

Attractors in Sequence Space: Agent‐Based Exploration of MHC I Binding Peptides

Natalie Jäger, Paul Wrede, Peter Walden, 2010, Molecular informatics.

Mimotopes for tumor‐specific T lymphocytes in human cancer determined with combinatorial peptide libraries

Peter Walden, Wolfram Sterry, W. Sterry, 2001, European journal of immunology.

Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries

K. Wiesmüller, E. Joly, P. Walden, 1998, European journal of immunology.

Connecting signaling and metabolic pathways in EGF receptor-mediated oncogenesis of glioblastoma

Saikat Chakrabarti, Krishna Kumar, Peter Walden, 2019, PLoS Comput. Biol..

Antigen Presentation: Paradigm Lost?

J. Klein, P. Walden, 1986 .

Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.

J. Klein, Z. Nagy, P. Walden, 1986, The Journal of molecular and cellular immunology : JMCI.

Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.

K. Wiesmüller, R. Brock, P. Walden, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.

S. Kienle, K. Wiesmüller, P. Walden, 1996, Journal of immunology.

Evidence for a large double-cruciform DNA structure on the X chromosome of human and chimpanzee

P. Wrede, P. Walden, A. Bredenbeck, 2007, Human Genetics.

New and emerging vaccination strategies for prevention and treatment of dermatological diseases

W. Sterry, P. Walden, 2004, Expert review of vaccines.

Detection and Quantification of CD4+ T Cells with Specificity for a New Major Histocompatibility Complex Class II-Restricted Influenza A Virus Matrix Protein Epitope in Peripheral Blood of Influenza Patients

G. Jung, P. Walden, T. Linnemann, 2000, Journal of Virology.

Tolerance to Amino Acid Variations in Peptides Binding to the Major Histocompatibility Complex Class I Protein H-2Kb(*)

Stefan Kienle, Karl-Heinz Wiesmüller, Peter Walden, 1995, The Journal of Biological Chemistry.

Diverse HLA-I Peptide Repertoires of the APC Lines MUTZ3-Derived Immature and Mature Dendritic Cells and THP1-Derived Macrophages

P. Walden, R. Baleeiro, S. Jarmalavicius, 2016, The Journal of Immunology.

Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma

W. Sterry, U. Trefzer, M. Hofmann, 2008, Journal of immunotherapy.

Therapeutic vaccination for the treatment of malignant melanoma.

P. Walden, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines.

A. Dalgleish, R. Pettengell, P. Walden, 2000, Biochimica et biophysica acta.

Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results.

K. Sparbier, W. Sterry, A. Milling, 2005, Vaccine.

Electrophoresis‐related protein modification: Alkylation of carboxy residues revealed by mass spectrometry

K. Sparbier, M. Steup, S. Haebel, 1998, Electrophoresis.

Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries

S. Kienle, K. Wiesmüller, P. Walden, 1995, The Journal of experimental medicine.

Large molecular systems landscape uncovers T cell trapping in human skin cancer

Walter Schubert, Reyk Hillert, Andreas Krusche, 2016, Scientific Reports.

T-cell epitope determination.

P. Walden, P Walden, 1996, Current opinion in immunology.

Sequit: software for de novo peptide sequencing by matrix-assisted laser desorption/ionization post-source decay mass spectrometry.

Peter Walden, P. Walden, Rodion Demine, 2004, Rapid communications in mass spectrometry : RCM.

High Immunogenicity of the Human Leukocyte Antigen Peptidomes of Melanoma Tumor Cells*

Y. Welte, P. Walden, S. Jarmalavicius, 2012, The Journal of Biological Chemistry.

Proteome Serological Determination of Tumor-Associated Antigens in Melanoma

Peter Walden, Wolfram Sterry, W. Sterry, 2009, PloS one.

An automated prediction of MHC class I-binding peptides based on positional scanning with peptide libraries

Taku Suto, Ko Okumura, Toshisuke Kawasaki, 2000, Immunogenetics.

HLA class I-restricted T cell epitopes isolated and identified from myeloid leukemia cells

P. Walden, P. le Coutre, Lydon Wainaina Nyambura, 2019, Scientific Reports.

Identification of Noncanonical Melanoma-Associated T Cell Epitopes for Cancer Immunotherapy1

P. Wrede, Alireza Givehchi, W. Sterry, 2005, The Journal of Immunology.

Class of TCR Antagonists -Hydroxy Peptides: A New N Cutting Edge:

Peter Walden, Sascha Hin, Claus Zabel, 2013 .

Elucidation of T-cell epitopes: a synthetic approach with random peptide libraries.

K. Wiesmüller, P. Walden, G. Jung, 1995, Biochemical Society transactions.

Anti‐tumor immune responses and tumor regression induced with mimotopes of a tumor‐associated T cell epitope

J. Muche, A. Lukowsky, W. Sterry, 2003, European journal of immunology.

Effects of cognate peptides on cytolytic and proliferative activities of cloned cytotoxic T lymphocytes.

H. Eisen, P. Walden, J. Dutz, 1992, International immunology.

Mimotopes of tumor-associated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries

Karl-Heinz Wiesmüller, Peter Walden, K. Wiesmüller, 2003, Molecular biotechnology.

A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma.

W. Sterry, K. Wiesmüller, P. Walden, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Cognate peptide-induced destruction of CD8+ cytotoxic T lymphocytes is due to fratricide.

H. Eisen, P. Walden, M. Su, 1993, Journal of immunology.

A Strategy for the Identification of Canonical and Non‐canonical MHC I‐binding Epitopes Using an ANN‐based Epitope Prediction Algorithm

Paul Wrede, Matthias Filter, Alireza Givehchi, 2006 .

Biochemical determination of natural tumor-associated T-cell epitopes

P. Walden, Tumenjargal Sherev, Rodion Demine, 2003, Molecular biotechnology.

Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes

P. Walden, G. Stuhler, 1994, Cancer Immunology, Immunotherapy.

Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

A. Gross, L. Kanz, P. Brossart, 2003, Nature Medicine.

Fine specificity analysis of lactate dehydrogenase B‐specific proliferating T cell clones: implications for the mechanism of alloreactivity

J. Klein, Z. Nagy, C. Servis, 1985, European journal of immunology.

Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology

S. Sundar, Syamal Roy, Michael Forgber, 2006, PloS one.

A Polymorphic Microsatellite Repeat within the ECE-1c Promoter Is Involved in Transcriptional Start Site Determination, Human Evolution, and Alzheimer's Disease

W. Maier, M. Klein, J. Kornhuber, 2012, The Journal of Neuroscience.

Hybrid cell vaccination in cancer immunotherapy. Recruitment and activation of T cell help for induction of anti tumour cytotoxic T cells.

U. Trefzer, P. Walden, G. Stuhler, 1998, Advances in experimental medicine and biology.

Glycosylation of Erythrocyte Spectrin and Its Modification in Visceral Leishmaniasis

S. Sundar, Michael Forgber, P. Walden, 2011, PloS one.

Sialoglycosylation of RBC in Visceral Leishmaniasis Leads to Enhanced Oxidative Stress, Calpain-Induced Fragmentation of Spectrin and Hemolysis

C. Mandal, P. Walden, Kaushik Bhattacharya, 2012, PloS one.

Imaging cycler microscopy

Walter Schubert, Reyk Hillert, Andreas Dress, 2014, Proceedings of the National Academy of Sciences.

Impact of Leishmania donovani infection on the HLA I self peptide repertoire of human macrophages

P. Walden, S. Jarmalavicius, Lydon Wainaina Nyambura, 2018, PloS one.

Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes.

H. Eisen, P. Walden, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.

P. Walden, S. Marusić-Galesić, 1995, Immunology.

Combined laser tweezers and dielectric field cage for the analysis of receptor‐ligand interactions on single cells

G. Fuhr, T. Müller, T. Schnelle, 2001, Electrophoresis.

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer

C. Chelala, N. Lemoine, Yaohe Wang, 2023, Journal for ImmunoTherapy of Cancer.

Identification of the testis‐specific protein 10 (TSGA10) as serologically defined tumour‐associated antigen in primary cutaneous T‐cell lymphoma

W. Sterry, P. Walden, K. Peris, 2005, The British journal of dermatology.

Identification of New Antigens in Visceral Leishmaniasis by Expression Cloning and Immunoblotting with Sera of Kala-Azar Patients from Bihar, India

S. Sundar, Syamal Roy, Michael Forgber, 2005, Infection and Immunity.

Combinatorial chemistry by ant colony optimization.

Petra Schneider, Gisbert Schneider, Tiago Rodrigues, 2014, Future medicinal chemistry.

Exhaustive proteome mining for functional MHC-I ligands.

Christian P. Koch, G. Schneider, P. Wrede, 2013, ACS chemical biology.

Hybrid Cell Vaccination Resolves Leishmania donovani Infection by Eliciting a Strong CD8+ Cytotoxic T-Lymphocyte Response with Concomitant Suppression of Interleukin-10 (IL-10) but Not IL-4 or IL-13

S. K. Dana, Syamal Roy, T. De, 2007, Infection and Immunity.